About: Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. Its lead candidate is Zilosul, an injectable pentosan polysulfate sodium drugs for the treatment of osteoarthritis, mucopolysaccharidosis, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is headquartered in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.25 (-2.00%)
PAR ASX Paradigm Biopharmaceuticals Ltd
Carregando status da lista de acompanhamento…
Paradigm Biopharmaceuticals Ltd share price
PAR price activity
Último preço
Variação (24h)
AUD (%)
Volume
-
Volume (média 4 sem.)
-
Fechamento anterior
N/A
Último negócio
PAR price performance
0%
5D
-7,55%
1M
-27,94%
YTD
-30%
1Y
quote.marketSignals